Moderna, Inc. (0QF.F)

EUR 24.0

(-2.24%)

Total Liabilities Summary of Moderna, Inc.

Moderna, Inc.'s latest annual total liabilities in 2023 was 4.57 Billion USD , down -32.12% from previous year.
Moderna, Inc.'s latest quarterly total liabilities in 2024 Q2 was 3.96 Billion USD , up 1.43% from previous quarter.
Moderna, Inc. reported annual total liabilities of 6.73 Billion USD in 2022, down -36.0% from previous year.
Moderna, Inc. reported annual total liabilities of 10.52 Billion USD in 2021, up 120.38% from previous year.
Moderna, Inc. reported quarterly total liabilities of 3.96 Billion USD for 2024 Q2, up 1.43% from previous quarter.
Moderna, Inc. reported quarterly total liabilities of 5.26 Billion USD for 2023 Q1, down -21.87% from previous quarter.

Annual Total Liabilities Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Total Liabilities of Moderna, Inc. (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	4.57 Billion USD	-32.12%
2022	6.73 Billion USD	-36.0%
2021	10.52 Billion USD	120.38%
2020	4.77 Billion USD	1051.77%
2019	414.61 Million USD	-4.0%
2018	431.9 Million USD	-5.94%
2017	459.19 Million USD	-20.18%
2016	575.31 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	3.91 Billion USD	-14.44%
2024 Q2	3.96 Billion USD	1.43%
2023 Q1	5.26 Billion USD	-21.87%
2023 Q3	5.99 Billion USD	21.48%
2023 Q2	4.93 Billion USD	-6.21%
2023 FY	4.57 Billion USD	-32.12%
2023 Q4	4.57 Billion USD	-23.74%
2022 Q4	6.73 Billion USD	-16.48%
2022 Q3	8.06 Billion USD	0.07%
2022 Q2	8.05 Billion USD	-23.5%
2022 FY	6.73 Billion USD	-36.0%
2022 Q1	10.53 Billion USD	0.1%
2021 Q1	8.85 Billion USD	85.45%
2021 Q3	10.79 Billion USD	14.29%
2021 Q4	10.52 Billion USD	-2.55%
2021 FY	10.52 Billion USD	120.38%
2021 Q2	9.44 Billion USD	6.7%
2020 Q4	4.77 Billion USD	152.52%
2020 Q2	539.12 Million USD	26.36%
2020 Q1	426.66 Million USD	2.91%
2020 FY	4.77 Billion USD	1051.77%
2020 Q3	1.89 Billion USD	250.77%
2019 Q2	346.72 Million USD	-3.73%
2019 FY	414.61 Million USD	-4.0%
2019 Q4	414.61 Million USD	22.27%
2019 Q3	339.09 Million USD	-2.2%
2019 Q1	360.17 Million USD	-16.61%
2018 Q3	412.72 Million USD	0.0%
2018 FY	431.9 Million USD	-5.94%
2018 Q4	431.9 Million USD	4.65%
2017 Q4	459.19 Million USD	0.0%
2017 FY	459.19 Million USD	-20.18%
2016 FY	575.31 Million USD	0.0%

Peer Total Liabilities Comparison of Moderna, Inc.

Name	Total Liabilities	Total Liabilities Difference
BioNTech SE	2.76 Billion EUR	-65.628%
CureVac N.V.	271.53 Million EUR	-1583.781%
Biotest Aktiengesellschaft	945.4 Million EUR	-383.605%
Biotest Aktiengesellschaft	945.4 Million EUR	-383.605%
BRAIN Biotech AG	47.92 Million EUR	-9440.304%
Formycon AG	387.61 Million EUR	-1079.533%
Heidelberg Pharma AG	21.01 Million EUR	-21657.716%
Medigene AG	10.65 Million EUR	-42829.577%